Contents
- (1) The following definitions apply in this section.
- (1.1) For the purposes of the definition innovative drug in subs…
- (2) The purpose of this section is to implement Articles 20.48…
- (3) If a manufacturer seeks a notice of compliance for a new d…
- (4) The period specified in paragraph (3)(b) is lengthened to…
- (5) Subsection (3) does not apply if the innovative drug is no…
- (6) Paragraph (3)(a) does not apply to a manufacturer if the i…
- (7) Paragraph (3)(a) does not apply to a manufacturer if the m…
- (8) Paragraph (3)(b) does not apply to a manufacturer if the i…
- (9) The Minister shall maintain a register of innovative drugs…
(2)The purpose of this section is to implement Articles 20.48 and 20.49 of the Agreement between Canada, the United States of America and the United Mexican States, as defined in the definition Agreement in section 2 of the Canada–United States–Mexico Agreement Implementation Act, and paragraph 3 of Article 39 of the Agreement on Trade-related Aspects of Intellectual Property Rights set out in Annex 1C to the Agreement Establishing the World Trade Organization, as defined in the definition Agreement in subsection 2(1) of the World Trade Organization Agreement Implementation Act.
Federal laws of Canada reproduced under the Reproduction of Federal Law Order (SI/97-5); not the official version. Source: Justice Laws Website.